Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (20)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by McCartney, A C E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McCartney, A C E
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

British Medical Bulletin 51:678-693 (1995)
© 1995 The British Council

research-article

Pathology of ocular melanomas

A C E McCartney

Ophthalmic Pathology, UMDS, St Thomas' Hospital London, UK

Abstract

Primary ocular melanomas usually arise in the uvea, in the choroid and ciliary body. They metastasize primarily and intially exclusively, to the liver. Metastasis and survival is determined by the maximum tumour dimension, the number of epithelioid cells present within the tumour, vascular patterns within the tumour and nucleolar size and activity. Ganglioside and integrin profiles differ from cutaneous melanomas.

Iris melanocytic lesions tend not to metastasize, most being naevi of varying degrees of aggressiveness which may cause glaucoma and corneal decompensation.

Conjunctival melanoma is a rare unilateral tumour arising either in primary acquired melanosis or de novo rather than within a naevus. Survival of the patient depends on the location of the tumour and the histological subtype. Tumours not arising in the bulbar or limbal conjuctiva have a much poorer prognosis as do eyelid (cutaneous) melanomas if they involve the lid margin.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Arch OphthalmolHome page
E. Weis, C. P. Shah, M. Lajous, J. A. Shields, and C. L. Shields
The Association Between Host Susceptibility Factors and Uveal Melanoma: A Meta-analysis
Arch Ophthalmol, January 1, 2006; 124(1): 54 - 60.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
E. D. Feldman, J. F. Pingpank, and H. R. Alexander Jr.
Regional Treatment Options for Patients With Ocular Melanoma Metastatic to the Liver
Ann. Surg. Oncol., March 1, 2004; 11(3): 290 - 297.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
F Cuthbertson, J Luck, and S Rose
Malignant melanoma of the conjunctiva metastasising to the parotid gland
Br. J. Ophthalmol., November 1, 2003; 87(11): 1428 - 1429.
[Full Text]

Home page
 Arch DermatolHome page
E. A. Hurst, J. W. Harbour, and L. A. Cornelius
Ocular Melanoma: A Review and the Relationship to Cutaneous Melanoma
Arch Dermatol, August 1, 2003; 139(8): 1067 - 1073.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
A. Beliveau, M. Berube, P. Carrier, C. Mercier, and S. L. Guerin
Tumorigenicity of the Mixed Spindle-Epithelioid SP6.5 and Epithelioid TP17 Uveal Melanoma Cell Lines Is Differentially Related to {alpha}5{beta}1 Integrin Expression
Invest. Ophthalmol. Vis. Sci., November 1, 2001; 42(12): 3058 - 3065.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
A. Béliveau, M. Bérubé, A. Rousseau, G. Pelletier, and S. L. Guérin
Expression of Integrin {alpha}5{beta}1 and MMPs Associated with Epithelioid Morphology and Malignancy of Uveal Melanoma
Invest. Ophthalmol. Vis. Sci., July 1, 2000; 41(8): 2363 - 2372.
[Abstract] [Full Text]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.